Prior to forming NDI Medical, Mr. Thrope worked at NeuroControl Corporation as Project Director, National Sales Manager, and Vice President of New Business Development. During his tenure, the company attracted over $30 M in venture capital investment, conducted successful multicenter clinical trials for neurostimulation products, obtained FDA and international regulatory approvals for its technologies, gained reimbursement from third party payers, and sold and marketed its products worldwide. Mr. Thrope earned a bachelor's degree in biomedical engineering from Case Western Reserve University in Cleveland and attended graduate school in Business Administration at Kent State University. He has published and presented more than 50 academic articles and has over 60 neurostimulation patents issued and pending. Mr. Thrope is on the board of several private companies, investment funds, and non-profit organizations.

Warren M. Grill serves as NDI Medical’s Chief Scientific Officer and is presently the Addy Professor of Biomedical Engineering at Duke University, Durham, NC, USA, with secondary appointments in Neurobiology and Surgery. Dr. Grill received the B.S. degree in biomedical engineering with honors from Boston University and the Ph.D. in biomedical engineering from Case Western Reserve University, Cleveland, OH. His research interests are in neural engineering and neural prostheses including design and testing of electrodes and stimulation techniques, the electrical properties of tissues and cells, and computational neuroscience with applications in restoration of bladder function, treatment of movement disorders with deep brain stimulation, and multi-joint limb movement. He has authored 90 peer-reviewed publications, and is an inventor on 9 issued and 5 pending patents. In 2007 he was elected as a Fellow of the American Institute of Medical and Biological Engineering, in 2008 received the Capers & Marion McDonald Award for Excellence in Teaching and Research at Duke University, and in 2009 was inducted into the Bass Society of Fellows at Duke for excellence in teaching and research.

Pat Shrader is Senior Vice President, Regulatory and External Affairs for Becton, Dickinson and Company (BD), a position she has held since 2004. Her responsibilities include interfacing with the US FDA and similar agencies internationally on regulatory issues; she also has overall responsibility for Public Policy, Communications, and Social Investing. Prior to her current role, Pat was Director of Regulatory Affairs for BD Diagnostics. Pat joined BD in 1995. Prior to joining BD, Pat was counsel with the Washington DC based law firm, Hogan & Hartson, as a member of the Administrative Law group.

Les Vinney is currently Senior Advisor of STERIS Corporation, and through September, 2007 was the Company’s President and Chief Executive Officer, and through July, 2007  a member of its Board of Directors. Les Vinney joined STERIS Corporation in August of 1999 as Senior Vice President and Chief Financial Officer. He became Senior Vice President, Finance and Operations in October 1999. In March 2000, he was elected President and Chief Operating Officer and a member of STERIS’s Board of Directors, and became STERIS Corporation’s President and CEO in July 2000.

Prior to joining STERIS, Mr. Vinney served as Senior Vice President and Chief Financial Officer at The BF Goodrich Company. He joined BF Goodrich in 1991 as Vice President of Finance, Specialty Polymers and Chemicals. He later became a company Vice President and Group President, Sealants, Coatings, and Adhesives. He was named BF Goodrich’s Vice President and Treasurer in 1997 and was elected Senior Vice President and Chief Financial Officer in 1998.

Before his career at BF Goodrich, Mr. Vinney held a number of senior operating and financial management positions with Engelhard Corporation, including serving as Group Vice President, Engineered Materials. His career began at Exxon Corporation in 1972, where Mr. Vinney progressed through several financial management assignments.

Les Vinney holds a Bachelor of Arts degree in Economics and Political Science, and a Master of Business Administration degree, with distinction, both from Cornell University. Mr. Vinney serves as Chairman of NorTech (Northeast Ohio Technology Coalition) and serves as the chairman of Cleveland HeartLab.  He serves on the Boards of the Federal Reserve Bank of Cleveland, Campbell Soup Company, Patterson Companies, and University Hospitals, and previously served on the board of the Advanced Medical Technology Association (AdvaMed).

Prior to forming NDI Medical, Mr. Thrope worked at NeuroControl Corporation as Project Director, National Sales Manager, and Vice President of New Business Development. During his tenure, the company attracted over $30 M in venture capital investment, conducted successful multicenter clinical trials for neurostimulation products, obtained FDA and international regulatory approvals for its technologies, gained reimbursement from third party payers, and sold and marketed its products worldwide. Mr. Thrope earned a bachelor's degree in biomedical engineering from Case Western Reserve University in Cleveland and attended graduate school in Business Administration at Kent State University. He has published and presented more than 50 academic articles and has over 60 neurostimulation patents issued and pending. Mr. Thrope is on the board of several private companies, investment funds, and non-profit organizations.

Bob Blankenship joined NDI Medical as the CFO in 2005 with over 20 years experience in the health care industry. He worked for Marconi Medical Systems as Vice President of Finance and Corporate Controller, managing the worldwide financial reporting, budgeting and strategic planning operations for the Company. He led the implementation of a global reporting package that streamlined the reporting process for all operations. He also was involved with the evaluation of potential acquisition targets and the integration of an acquired company into the Organization. During that time Marconi Medical Systems grew in revenue more than $800 million before it was acquired by Philips Medical Systems. After the acquisition he continued with Philips Medical Systems as the Vice President and CFO of the CT/MR Division where he managed the worldwide financial functions of the company's $1.2 billion multi-product business line as well as the billion dollar merger of the Marconi Medical and Philips Imaging divisions. Prior to this, he was an accountant at Ernst & Young. Mr. Blankenship earned a M.B.A. from Miami University in Oxford, Ohio. He is a certified public accountant.

Juliana Elstad’s career has been principally devoted to the medical device fields of neuromodulation and cardiac rhythm management. Prior to joining NDI, she founded Elstad Medical, providing business development, marketing, and strategy consulting to early-stage medical device companies. Previously, Ms. Elstad led business development efforts at Medtronic, Inc., evaluating public small-cap companies, privately held startups, joint ventures, and collaborations with major U.S. universities. In addition to her business development role, she coordinated strategic planning, led a cross-functional committee to prioritize Medtronic’s neuromodulation R&D efforts, and performed marketing analyses of new therapies, for which she was selected as one of the top twenty-five Medtronic Emerging Leaders. Prior to Medtronic, she was a management consultant with McKinsey & Company and a senior auditor with Arthur Andersen. She earned her MBA from Wharton School, University of Pennsylvania and a master’s degree in economics from the Moscow University of International Relations.